Massachusetts biotech incentives eclipsed by competitive states

Boston Globe | 
Massachusetts has made its way over the past half-dozen years to being an undisputed leader in biotechnology and life sciences ...

Full genome sequencing is medically promising, but still expensive

Boston Herald | 
Genome sequencing holds great potential for diagnosing diseases, finding treatments and ultimately cutting medical costs, experts say, but insurance companies ...

Precision medicine: reading genes and treating people before they get sick

Boston Herald | 
Doctors and researchers around Boston are working to make drugs and health care delivery more individualized than ever. And patients ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists